Lactobacillus reuteri

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Lactobacillus reuteri
DrugBank Accession Number
DB14224
Background

Not Available

Type
Biotech
Groups
Experimental, Investigational
Synonyms
  • L. reuteri
  • Lactobacillus fermentum biotype II whole
  • Lactobacillus fermentum subsp. reuteri whole
  • Lactobacillus reuteri whole

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
Not Available

Interactions

Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Lacto Bella YLactobacillus reuteri (0.6 g/100mL) + Lavender oil (0.8 g/100mL) + Sodium chloride (0.3 g/100mL) + Sophora flavescens root (0.0015 g/100mL)GelVaginalBella Lab Co., Ltd.2018-04-27Not applicableUS flag
MogutLactobacillus reuteri (20 g/100mL) + Enterococcus faecium (20 g/100mL)LiquidOralCoenbio Co., Ltd.2017-08-01Not applicableUS flag
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Lacto Bella YLactobacillus reuteri (0.6 g/100mL) + Lavender oil (0.8 g/100mL) + Sodium chloride (0.3 g/100mL) + Sophora flavescens root (0.0015 g/100mL)GelVaginalBella Lab Co., Ltd.2018-04-27Not applicableUS flag
MogutLactobacillus reuteri (20 g/100mL) + Enterococcus faecium (20 g/100mL)LiquidOralCoenbio Co., Ltd.2017-08-01Not applicableUS flag

Categories

Drug Categories
Not Available
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
9913I24QEE
CAS number
Not Available

References

General References
Not Available
RxNav
285156
Wikipedia
Lactobacillus_reuteri

Clinical Trials

Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
PhaseStatusPurposeConditionsCount
4CompletedPreventionAntibiotic Associated Diarrhoea1
4CompletedPreventionAntibiotic Associated Diarrhoea / Diarrhea1
4CompletedTreatmentBacterial Vaginosis (BV)1
4CompletedTreatmentCerebral Palsy (CP) / Chronic Constipation1
4CompletedTreatmentHelicobacter Pylori Infection1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
GelVaginal
LiquidOral
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created at July 04, 2018 22:48 / Updated at June 12, 2020 16:53